Zinc & Castor Oil OintmentZinc Oxide 7.5%w/wCastor Oil 50%w/w

Land: Irland

Språk: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv ingrediens:

Zinc oxide; Castor oil

Tilgjengelig fra:

Ovelle Limited

ATC-kode:

D02AB

INN (International Name):

Zinc oxide; Castor oil

Dosering :

7.5 %w/w + 50 percent weight/weight

Legemiddelform:

Ointment

Resept typen:

Product not subject to medical prescription

Terapeutisk område:

Zinc products

Autorisasjon status:

Marketed

Autorisasjon dato:

1992-10-13

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Zinc & Castor Oil Ointment
Zinc Oxide 7.5%w/w
Castor Oil 50%w/w
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Zinc Oxide 7.5% w/w and Castor Oil, virgin 50% w/w.
Excipients: contains 2.0% w/w Cetostearyl Alcohol and 30.5% w/w
Arachis Oil
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Ointment.
A white homogeneous ointment with a characteristic odour and a smooth
oily texture.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
(a)
Zinc & Castor Oil Ointment is used as a topical emollient and
astringent skin application.
(b)
It acts as a soothing and protective application in eczema and as a
protective for slight excoriations and sore areas
of the skin. It is a protection against nappy rash in infants.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Zinc & Castor Oil Ointment is applied topically and is for external
use only.
Recommended Use:
As an emollient
and protective for topical
management
of nappy rash,
pruritus and other mild
irritative rashes.
Apply as required after cleansing the affected area. If symptoms
persist consult your doctor.
4.3 CONTRAINDICATIONS
Zinc & Castor Oil Ointment is contra-indicated in patients with a
known sensitivity to its ingredients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Zinc & Castor Oil Ointment contains arachis oil (peanut oil). If you
are allergic to peanut or soya, do not use this
medicinal product. Zinc & Castor Oil Ointment may cause local skin
reactions (e.g. contact dermatitis).
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
__